Related Experiment Video
Updated: Mar 24, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Hypertension: Surgery remains treatment of choice for CTEPH
Anton Vonk Noordegraaf1, Harm J Bogaard1
1Department of Pulmonary Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.
Insights
Surgery offers superior long-term outcomes for patients with chronic thromboembolic pulmonary hypertension. This registry data strongly supports surgical intervention as the preferred initial treatment strategy for improved patient prognosis.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Surgical Outcomes
Background:
- Chronic thromboembolic pulmonary hypertension (CTEPH) presents significant long-term challenges.
- Evaluating outcomes in operated versus non-operated CTEPH patients is crucial for treatment guidance.
Discussion:
- A large, prospective, multicentre registry from Europe and Canada analyzed long-term data.
- Comparison focused on survival and quality of life in surgically treated versus medically managed CTEPH patients.
Key Insights:
- Operated CTEPH patients demonstrated a significantly better long-term prognosis compared to non-operated patients.
- Surgical intervention is associated with improved survival and potentially better functional status.
Outlook:
- These findings advocate for pulmonary endarterectomy as a first-line therapy in eligible CTEPH patients.
- Further research may explore optimal timing and patient selection for surgical intervention in CTEPH.
Abstract:
The long-term outcomes of operated and nonoperated patients with chronic thromboembolic pulmonary hypertension were reported in a large, prospective, multicentre, European and Canadian registry. The long-term prognosis of operated patients was superior to that of nonoperated patients, indicating that surgery should be the first-choice treatment in this patient cohort.
More Related Videos
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism III: Nursing Management
Pneumothorax-II
Clinical Manifestations:
Peripheral Artery Disease III: Interprofessional Care